José Antonio Matus

José Antonio Matus is a Mexican lawyer and coordinator of the HIV Healthcare Foundation (AHF) in Mexico. He has been vocal about the challenges faced by Latin American countries in accessing innovative HIV treatments, specifically highlighting the exclusion of Lenacapavir from a pricing agreement between Gilead Sciences and the Global Fund. Matus has emphasized that this lack of access leads to increased healthcare costs and hinders the fight against HIV in Mexico, where the number of diagnosed cases is on the rise.